Ragnhild Berg

New Hybrid Treatment Forces Cancer Cells to Starve

4 min read

New Hybrid Treatment Forces Cancer Cells to Starve

The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a...

Read More

Eleos Health and Kipu Health Announce Partnership to Deliver AI-Powered Insights to Behavioral Health Providers

2 min read

Eleos Health and Kipu Health Announce Partnership to Deliver AI-Powered Insights to Behavioral Health Providers

Kipu Health, the leading technology partner for mental health and addiction service providers, and Eleos Health, the leader in...

Read More

Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon® for the treatment of primary IgA nephropathy USA – English 

2 min read

Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon® for the treatment of primary IgA nephropathy USA – English 

Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (‘Calliditas’) today announced that its partner Everest Medicines (HKEX: 1952.HK) (‘Everest’) announced that China’s National Medical...

Read More

Glassbeam Awarded FedRAMP® ‘In-Process’ Status for its SaaS analytics solution for connected medical systems

2 min read

Glassbeam Awarded FedRAMP® ‘In-Process’ Status for its SaaS analytics solution for connected medical systems

Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced it has...

Read More

K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer

3 min read

K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer

K36 Therapeutics, Inc. (“K36”), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor KTX-1001 for...

Read More

RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology

1 min read

RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology

RemeGen Co., Ltd. (“RemeGen” or “the Company”) (HKG: 9995, SHA: 688331), a commercial-stage biotechnology company, is invited to present telitacicept...

Read More

Sigrid Therapeutics Launches the Glucose Stabiliser in the U.S.

Sigrid Therapeutics Launches the Glucose Stabiliser in the U.S.

Read More

Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT

2 min read

Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced that it...

Read More

Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility

2 min read

Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility

As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung...

Read More

Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery

2 min read

Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery

Terray Therapeutics, a biotechnology company integrating scale experimentation and generative AI to improve the speed, cost, and...

Read More